Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Burzynski Clinic Presents Over Five Years Survival Data From Phase II Trials of ANP for Inoperable Brain Tumors at the Congress

11/15/2013 | 09:34pm US/Eastern

The Burzynski Clinic (BC) announced today that it made a keynote speaker presentation at the 2nd Annual Congress of Asia-Pacific Academy of Anti-Aging Medicine in Beijing, China. Based on the presentation in Beijing, a total of 401 eligible patients (patients who received over 28 days of treatment) with advanced inoperable brain tumors have been treated with antineoplaston A10 and antineoplastons AS2-1 therapy (ANP) in phase II studies. Most of the patients (87%) were diagnosed with high-grade tumors and the remaining patients were diagnosed with low-grade tumors. The patients were diagnosed by pathologists not associated with BC and objective responses were verified by Central Radiology Review. The group of 77 patients (19%) survived over five years from the treatment start. Of particular interest were results in patients with brainstem gliomas. The group of 17 patients with brainstem glioma underwent the treatment and 65% of these patients survived over five years. An additional group of 42 patients diagnosed with diffuse intrinsic pontine glioma (DIPG) have been treated and a total of 19% survived over five years.

The quality of survival is very good and there is no long-term toxicity related to ANP.

These clinical results are very encouraging, since they describe a positive ANP effect on some of the worst malignancies in the entire oncology field, but they will require FDA approval.

Burzynski Clinic is committed to developing treatments for cancer based on genomic and epigenomic principles.

Forward-looking statements in this release are made pursuant to the safe harbor provisions of the federal securities laws. Information contained in forward-looking statements is based on current expectations and is subject to change, and future events may differ materially from those discussed herein due to a number of factors, including, but not limited to, risks and uncertainties related to the clinic's ability to use Antineoplastons A10 and AS2-1. Burzynski Clinic does not undertake to update any such forward-looking statements or to publicly announce developments or events relating to the matters described herein.

For Burzynski Clinic
Carolyn Powers, 713-335-5664
carolyn@burzynskiclinic.com


© Business Wire 2013
React to this article
Latest news
Date Title
1m ago EASYHOTEL : Vattenfall divests Danish power plant
1m ago CELLCURA ASA : Received notice of conversion of convertible loan
1m ago WTO WORLD TRADE ORGANIZATION : Programme for helping poorest countries trade is to be extended
1m ago FINMECCANICA : Press Release
1m ago GOVERNMENT OF CANADA : Unveils Value Proposition Guide
1m ago OPTIBIOTIX HEALTH : Vattenfall divests Danish power plant
1m ago AVANTA SERVICED OFFICE : Vattenfall divests Danish power plant
1m ago MARIMEDIA : Vattenfall divests Danish power plant
1m ago LXB RETAIL PROPERTIES : Vattenfall divests Danish power plant
1m ago TIZIANA LIFE SCIENCES : Vattenfall divests Danish power plant
Latest news
Advertisement
Hot News 
DIXONS CARPHONE : *exane bnp raises dixons carphone price target to 510 (450) pence - 'outperform'
BERKELEY MINERAL RESOURCES : Obsidian IR
ATLANTIS RESOURCES : Makes First MeyGen Facility Drawdown
FINISH LINE : Reports Third Quarter Fiscal Year 2015 Results
MARTINCO : More unwelcome surprises regarding deposit protection
Most Read News
1d ago Wall St. has best second-day gain since 2011 on Fed optimism
1d agoDJKEPPEL LAND : Correction to Keppel Land to Buy 75% Stake in Array Article (on Friday)
1d ago WELLS FARGO : exec Petrilla is new head of state's California-China trade office
1d ago Unilever drops mayonnaise suit against Just Mayo maker
1d ago Brazil's Rousseff vows clean-up of scandal-tainted Petrobras
Most recommended articles
1m ago Washington closes out last big position in Wall Street bailout
4m ago ECB won't hesitate to act if needed, Praet says
5m ago DEUTSCHE BOERSE : Germany seeks plans to boost start-up IPOs
8m ago Alstom to absorb U.S. bribery fine despite GE sale
9m ago Factbox - European companies adjust strategies in Russia
Dynamic quotes  
ON
| OFF